The current study aimed to use MRI to assess the therapeutic efficacy of a dual route of administration of self‐complementary adeno‐associated virus expressing ovine CLN5 (scAAV9/oCLN5) in sheep with CLN5 Batten disease (Murray, Wellby, et al. This evidence concerns the gene CLN5 and juvenile neuronal ceroid lipofuscinosis.